Prostaglandin E2 enhances, and leukotriene C4 inhibits, interleukin-1 inhibition of WEHI-3B cell growth

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00205804PMID 2535792PMCID PMC11038761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations of MCF-7 Human Breast Cancer Cell after Prostaglandins PGA1 and PGF2α‘Treatment

  1987cited by this paper
• Leukotriene D4 and indomethacin enhance additively the macrophage cytostatic activity in vitro towards MOPC-315 tumour cells.

  1987cited by this paper
• Alterations of MCF-7 human breast cancer cell after prostaglandins PGA1 and PGF2 alpha treatment.

  1987cited by this paper
• Tumor necrosis factor as an interleukin 1-dependent differentiation inducing factor (D-factor) for mouse myeloid leukemic cells.

  1987cited by this paper
• Multiple biological activities of human recombinant interleukin 1.

  1986cited by this paper
• Evidence for the role of leukotrienes C4 and D4 as essential intermediates in CSF-stimulated human myeloid colony formation.

  1986cited by this paper
• Prostaglandins as endogenous mediators of interleukin 1 production.

  1986cited by this paper
• Cyclooxygenase inhibitors promote the leukotriene C4 induced release of beta-glucuronidase from rat peritoneal macrophages: prostaglandin E2 suppresses.

  1986cited by this paper
• Human interleukin 1 is a cytocidal factor for several tumor cell lines.

  1985cited by this paper
• Leukotrienes augment interleukin 1 production by human monocytes.

  1985cited by this paper
• The role of arachidonic acid metabolism in the activities of interleukin 1 and 2.

  1985cited by this paper
• The influence of lipoxygenase inhibitors on the in vitro production of human leukocytic pyrogen and lymphocyte activating factor (interleukin-1).

  1984cited by this paper
• Autoinduction of differentiation in wehi‐3B leukemia cells

  1982cited by this paper
• Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1.

  1982cited by this paper
• Radioimmunoassay of the leukotrienes of slow reacting substance of anaphylaxis.

  1981cited by this paper
• In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells.

  1980cited by this paper

• Aminosalicylates: Potential Antineoplastic Actions in Colon Cancer Prevention

  2002cites this paper
• Cancer immunotherapy: potential involvement of mediators

  1997cites this paper
• Involvement of inflammatory mediators in macrophage antitumor activity

  1993cites this paper
• Activity of human peritoneal macrophages against a human tumor: role of tumor necrosis factor-alpha, PGE2 and nitrite, in vitro studies.

  1993cites this paper
• Tumour necrosis factor in inflammation: relation to other mediators and to macrophage antitumour defence.

  1991cites this paper
• Inflammation amplifies the antitumor cytostasis by human peritoneal macrophages

  1991cites this paper
• Macrophage cytokines render WEHI-3B tumor cells susceptible to cytostasis by prostaglandins.

  1990cites this paper
• Interactions between inflammatory mediators in expression of antitumor cytostatic activity of macrophages.

  1990cites this paper
• Invited Review

  year unknowncites this paper